NEWS
February 10, 2021
PGV adopted for a NEDO's program, "2020 Innovation Promotion Project for Accelerating AI Chip Development."
NEDO (New Energy and Industrial Technology Development Organization) adopted PGV’s proposal for "2020 Innovation Promotion Project for Accelerating AI Chip Development.” In this project, PGV plans to improve the productivity of the AI development environments by developing "pre-processing chips," equipped with data pre-processing technology, and "brain wave AI development tools."
January 20, 2021
PGV introduced in a Nikkei Business Daily's article about Osaka University.
A Nikkei Business Daily's article covered industry-academia collaboration and commercialization by the Institute of Scientific and Industrial Research, Osaka University. The article introduced PGV business and an interview with PGV founder, Professor Sekitani, Osaka University.
December 1, 2020
PGV concludes a joint research agreement with Osaka University.
PGV and Osaka University agree to jointly research and develop diagnostic technology for neurological diseases such as dementia using PGV patch-type EEG.
September 2, 2020
Monthly Journal of Pharmaceutical Business (2020.09.01, Iyaku Keizai) carries an interview article with PGV CEO.
August 20, 2020
PGV obtains License Certificate for Selling and Leasing Specially-Controlled Medical Device on August 17, 2020.
August 19, 2020
PGV obtains a medical device certification for “Patch-Type EEG HARU-1.”
July 14, 2020
PGV raises 150 million yen through third-party allotment of new shares to OSAKA University Venture Capital Co., Ltd.
April 13, 2020
Recruiting information updated; an opening for a brain-wave data analyst position.
April 1, 2020
2020.4.1 Nikkei Business Daily covers PGV’s business leveraging its patch-type EEG sensor, jointly developed with Nippon Mektron.
March 13, 2020